Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 4, 2025
Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-upDaphne van Vliet, Eline H Ploumen, Tineke H Pinxterhuis, et al.
International Journal of Cardiology. Heart & Vasculature|July 21, 2025
Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trialsDaphne van Vliet, Tineke H Pinxterhuis, Eline H Ploumen, et al.
Circulation|November 4, 2005
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathySaman Nazarian, David A Bluemke, Albert C Lardo, et al.
Cardiovascular Diagnosis and Therapy|September 7, 2023
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
Cardiovascular Intervention and Therapeutics|December 19, 2024
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial diseaseTineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, et al.
Atherosclerosis|May 31, 2022
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
International Journal of Cardiology|December 10, 2022
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial diseaseTineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, et al.
JACC. Cardiovascular Interventions|March 16, 2020
Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-IIIAriel Roguin, Rosaly A Buiten, Carine J M Doggen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 22, 2024
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trialsEline H Ploumen, Edimir Semedo, Carine J M Doggen, et al.
American Heart Journal|April 15, 2018
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trialLiefke C van der Heijden, Marlies M Kok, Paolo Zocca, et al.
Pageof 40